Emily English - 03 Jan 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Operations Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
Issuer symbol
RNAC
Transactions as of
03 Jan 2025
Net transactions value
-$30,149
Form type
4
Filing time
07 Jan 2025, 20:05:11 UTC
Previous filing
06 Jan 2025
Next filing
16 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale $14,899 -891 -2.1% $16.72 41,132 03 Jan 2025 Direct F1
transaction RNAC Common Stock Sale $15,250 -906 -2.2% $16.83 40,226 06 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.